公司资料
Tenon Medical 股价、新闻与催化剂
- 股票代码:
- TNON
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
4.04 USD (-1.22%)
收盘价
最后更新: 2026年10月1日
7.24M USD
市值
股价为何变动
截至 2026年10月1日，TNON 下跌 1.22%，收于 $4.04。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Sacroiliac Joint Device Company
Tenon Medical develops implants and instruments for minimally invasive fusion of the sacroiliac joint. Its technology targets chronic lower-back pain associated with SI-joint dysfunction.
Catamaran SI Joint Fusion System
The Catamaran system uses a titanium implant placed across the SI joint through a posterior-inferior approach. The implant is designed to stabilize the joint and create a path for bone fusion.
Procedural Simplicity
The surgical approach is intended to use a small incision, limited dissection, and direct access to the joint. Tenon provides dedicated instruments and training to help surgeons adopt a reproducible workflow.
Surgeon and Distributor Channel
The company commercializes Catamaran through direct representatives and distributors serving spine surgeons, neurosurgeons, and orthopedic specialists. Education, case support, and new-site activation are central to adoption.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。